2026 MIPS Measure #516: Hepatitis C Virus (HCV): Sustained Virological Response (SVR)
Quality ID516
eMeasure IDNone
NQFNone
High-Priority MeasureYes
Specifications
—
Measure TypeProcess
MVP IDYes (MVP ID: M1368, M1422)
Specialty
Family Medicine
Gastroenterology
Infectious Disease
Internal Medicine
Measure Description
Percentage of patients aged greater than or equal to 18 years with active hepatitis C (HCV) with negative/undetectable HCV ribonucleic acid (RNA) at least 20 weeks to 12 months after positive/detectable HCV RNA test result.
Measure Submission Type
MIPS clinical quality measures (MIPS CQMs)